Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials
Gyre Therapeutics, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Winton Capital Management David Harding | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.47 | 3,250 | $1,527.50 | 24,541 | 2022-08-09 | Filing | |
| $0.47 | 3,250 | $1,527.50 | 6,500 | 2022-08-09 | Filing | |
| $0.47 | 3,250 | $1,527.50 | 9,417 | 2022-08-09 | Filing | |
| $0.46 | 3,250 | $1,495.00 | 21,291 | 2022-02-09 | Filing | |
| $0.46 | 3,250 | $1,495.00 | 3,250 | 2022-02-09 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.07 | 558 | $5,619.06 | 2,806,084 | 2025-05-28 | Filing | |
| $10.28 | 2,000 | $20,560.00 | 2,806,642 | 2025-05-27 | Filing | |
| $10.24 | 182 | $1,863.68 | 2,808,642 | 2025-05-23 | Filing | |
| $10.97 | 2,000 | $21,940.00 | 2,808,824 | 2025-05-22 | Filing | |
| $10.83 | 2,000 | $21,660.00 | 2,810,824 | 2025-05-21 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 43 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% |